|
1. Salgado AJ, Coutinho OP, Reis RL: Bone tissue engineering: State of the art and future trends. Macromolecular Bioscience 2004, 4(8):743-765. 2. Chen B, Lin H, Wang J, Zhao Y, Wang B, Zhao W, Sun W, Dai J: Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 2007, 28(6):1027-1035. 3. Martino MM, Briquez PS, Ranga A, Lutolf MP, Hubbell JA: Heparin-binding domain of fibrin (ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proceedings of the National Academy of Sciences 2013, 110(12):4563-4568. 4. Kisiel M, Klar AS, Ventura M, Buijs J, Mafina M-K, Cool SM, Hilborn J: Complexation and sequestration of BMP-2 from an ECM mimetic hyaluronan gel for improved bone formation. PLoS One 2013, 8(10):e78551. 5. Liao Y-H, Chang Y-H, Sung L-Y, Li K-C, Yeh C-L, Yen T-C, Hwang S-M, Lin K-J, Hu Y-C: Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b. Biomaterials 2014, 35(18):4901-4910. 6. Yan J, Zhang C, Zhao Y, Cao C, Wu K, Zhao L, Zhang Y: Non-viral oligonucleotide antimiR-138 delivery to mesenchymal stem cell sheets and the effect on osteogenesis. Biomaterials 2014, 35(27):7734-7749. 7. Schmoekel HG, Weber FE, Schense JC, Grätz KW, Schawalder P, Hubbell JA: Bone repair with a form of BMP‐2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnology and bioengineering 2005, 89(3):253-262. 8. Yeung ML, Bennasser Y, Le SY, Jeang KT: siRNA, miRNA and HIV: promises and challenges. Cell research 2005, 15(11):935. 9. Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, Comer G, Kopjar B: Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. JBJS 2013, 95(17):1537-1545. 10. DeVine JG, Dettori JR, France JC, Brodt E, McGuire RA: The use of rhBMP in spine surgery: is there a cancer risk? Evidence-based spine-care journal 2012, 3(02):035-041. 11. Lin C-Y, Chang Y-H, Li K-C, Lu C-H, Sung L-Y, Yeh C-L, Lin K-J, Huang S-F, Yen T-C, Hu Y-C: The use of ASCs engineered to express BMP2 or TGF-β3 within scaffold constructs to promote calvarial bone repair. Biomaterials 2013, 34(37):9401-9412. 12. Airenne KJ, Makkonen KE, Mahonen AJ, Yla-Herttuala S: In Vivo Application and Tracking of Baculovirus. Curr Gene Ther 2010, 10(3):187-194. 13. Mizuno H, Tobita M, Orbay H, Uysal AC, Lu F: Adipose-derived stem cells as a novel tool for future regenerative medicine. In: Stem Cells and Cancer Stem Cells, Volume 12. Springer; 2014: 165-174. 14. Zhang W, Zhu C, Wu Y, Ye D, Wang S, Zou D, Zhang X, Kaplan DL, Jiang X: VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur Cell Mater 2014, 27(12):1. 15. Wang Y, Mostafa NZ, Hsu CY, Rose L, Kucharki C, Yan J, Jiang H, Uludağ H: Modification of human BMSC with nanoparticles of polymeric biomaterials and plasmid DNA for BMP-2 secretion. Journal of Surgical Research 2013, 183(1):8-17. 16. Mizrahi O, Sheyn D, Tawackoli W, Kallai I, Oh A, Su S, Da X, Zarrini P, Cook-Wiens G, Gazit D: BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells. Gene therapy 2013, 20(4):370. 17. Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L, Li C, Xie L, Crane J, Wan M: PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nature medicine 2014, 20(11):1270. 18. Ju C, Liu RF, Zhang YW, Zhang Y, Zhou RH, Sun J, Lv XB, Zhang ZP: Mesenchymal stem cell-associated lncRNA in osteogenic differentiation. Biomed Pharmacother 2019, 115. 19. Yoshioka H, Yoshiko Y: The Roles of Long Non-Protein-Coding RNAs in Osteo-Adipogenic Lineage Commitment. Int J Mol Sci 2017, 18(6). 20. Zhang D, Xiong M, Xu C, Xiang P, Zhong X: Long Noncoding RNAs: An Overview. Methods Mol Biol 2016, 1402:287-295. 21. Yang QL, Jia LF, Li XB, Guo RZ, Huang YP, Zheng YF, Li WR: Long Noncoding RNAs: New Players in the Osteogenic Differentiation of Bone Marrow- and Adipose-Derived Mesenchymal Stem Cells. Stem Cell Rev Rep 2018, 14(3):297-308. 22. Gao Y, Xiao F, Wang C, Wang C, Cui P, Zhang X, Chen X: Long noncoding RNA MALAT1 promotes osterix expression to regulate osteogenic differentiation by targeting miRNA-143 in human bone marrow-derived mesenchymal stem cells. J Cell Biochem 2018, 119(8):6986-6996. 23. Liu Y, Zeng X, Miao J, Liu C, Wei F, Liu D, Zheng Z, Ting K, Wang C, Guo J: Upregulation of long noncoding RNA MEG3 inhibits the osteogenic differentiation of periodontal ligament cells. J Cell Physiol 2019, 234(4):4617-4626. 24. Li B, Xu H, Han H, Song S, Zhang X, Ouyang L, Qian C, Hong Y, Qiu Y, Zhou W et al: Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene 2018, 37(41):5508-5519. 25. Xu B, Gerin I, Miao HZ, Dang VP, Johnson CN, Xu RC, Chen XW, Cawthorn WP, MacDougald OA, Koenig RJ: Multiple Roles for the Non-Coding RNA SRA in Regulation of Adipogenesis and Insulin Sensitivity. Plos One 2010, 5(12). 26. Mckay DB, Xi LH, Barthel KKB, Cech TR: Structure and Function of Steroid Receptor RNA Activator Protein, the Proposed Partner of SRA Noncoding RNA. J Mol Biol 2014, 426(8):1766-1785. 27. Liu SN, Xu RC, Gerin I, Cawthorn WP, MacDougald OA, Chen XW, Saltiel AR, Koenig RJ, Xu B: SRA Regulates Adipogenesis by Modulating p38/JNK Phosphorylation and Stimulating Insulin Receptor Gene Expression and Downstream Signaling. Plos One 2014, 9(4). 28. Wei SJ, Du M, Jiang ZH, Hausman GJ, Zhang LF, Dodson MV: Long noncoding RNAs in regulating adipogenesis: new RNAs shed lights on obesity. Cell Mol Life Sci 2016, 73(10):2079-2087. 29. Sheng L, Ye L, Zhang D, Cawthorn WP, Xu B: New Insights Into the Long Non-coding RNA SRA: Physiological Functions and Mechanisms of Action. Front Med-Lausanne 2018, 5. 30. Pang WJ, Lin LG, Xiong Y, Wei N, Wang Y, Shen QW, Yang GS: Knockdown of PU.1 AS lncRNA Inhibits Adipogenesis Through Enhancing PU.1 mRNA Translation. J Cell Biochem 2013, 114(11):2500-2512. 31. Wei N, Wang Y, Xu RX, Wang GQ, Xiong Y, Yu TY, Yang GS, Pang WJ: PU.1 antisense lncRNA against its mRNA translation promotes adipogenesis in porcine preadipocytes. Anim Genet 2015, 46(2):133-140. 32. Jin CY, Zheng YF, Huang YP, Liu YS, Jia LF, Zhou YS: Long non-coding RNA MIAT knockdown promotes osteogenic differentiation of human adipose-derived stem cells. Cell Biol Int 2017, 41(1):33-41. 33. Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q, Cao J, Xie N, Velletri T, Zhang X et al: Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ 2016, 23(7):1128-1139. 34. Pang M, Woodward AW, Agarwal V, Guan X, Ha M, Ramachandran V, Chen X, Triplett BA, Stelly DM, Chen ZJ: Genome-wide analysis reveals rapid and dynamic changes in miRNA and siRNA sequence and expression during ovule and fiber development in allotetraploid cotton (Gossypium hirsutum L.). Genome biology 2009, 10(11):R122. 35. Somiari S, Glasspool-Malone J, Drabick JJ, Gilbert RA, Heller R, Jaroszeski MJ, Malone RW: Theory and in vivo application of electroporative gene delivery. Mol Ther 2000, 2(3):178-187. 36. Mello de Queiroz F, Sanchez A, Agarwal JR, Stuhmer W, Pardo LA: Nucleofection induces non-specific changes in the metabolic activity of transfected cells. Mol Biol Rep 2012, 39(3):2187-2194. 37. Li S, Huang L: Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene therapy 2006, 13(18):1313. 38. Sinn P, Sauter S, McCray Jr P: Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors–design, biosafety, and production. Gene therapy 2005, 12(14):1089. 39. Jung Y, Bauer G, Nolta JA: Concise review: induced pluripotent stem cell‐derived mesenchymal stem cells: progress toward safe clinical products. Stem cells 2012, 30(1):42-47. 40. Nonnenmacher M, Weber T: Intracellular transport of recombinant adeno-associated virus vectors. Gene therapy 2012, 19(6):649. 41. Kotterman MA, Schaffer DV: Engineering adeno-associated viruses for clinical gene therapy. Nature Reviews Genetics 2014, 15(7):445. 42. J Airenne K, Makkonen K-E, J Mahonen A, Yla-Herttuala S: In vivo application and tracking of baculovirus. Current gene therapy 2010, 10(3):187-194. 43. Wang S, Balasundaram G: Potential cancer gene therapy by baculoviral transduction. Current gene therapy 2010, 10(3):214-225. 44. Ho YC, Chung YC, Hwang SM, Wang KC, Hu YC: Transgene expression and differentiation of baculovirus‐transduced human mesenchymal stem cells. The journal of gene medicine 2005, 7(7):860-868. 45. Lin C-Y, Lin K-J, Kao C-Y, Chen M-C, Lo W-H, Yen T-C, Chang Y-H, Hu Y-C: The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. Biomaterials 2011, 32(27):6505-6514. 46. Chen H-C, Sung L-Y, Lo W-H, Chuang C-K, Wang Y-H, Lin J-L, Hu Y-C: Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene therapy 2008, 15(4):309. 47. Cheshenko N, Krougliak N, Eisensmith R, Krougliak V: A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 2001, 8(11):846. 48. Turan S, Galla M, Ernst E, Qiao J, Voelkel C, Schiedlmeier B, Zehe C, Bode J: Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. Journal of molecular biology 2011, 407(2):193-221. 49. Turan S, Zehe C, Kuehle J, Qiao J, Bode J: Recombinase-mediated cassette exchange (RMCE)—a rapidly-expanding toolbox for targeted genomic modifications. Gene 2013, 515(1):1-27. 50. Nakano M, Odaka K, Takahashi Y, Ishimura M, Saito I, Kanegae Y: Production of viral vectors using recombinase-mediated cassette exchange. Nucleic acids research 2005, 33(8):e76-e76. 51. Sung L-Y, Chen C-L, Lin S-Y, Hwang S-M, Lu C-H, Li K-C, Lan AS, Hu Y-C: Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study. Nucleic acids research 2013, 41(14):e139-e139. 52. Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J: The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem cells 2007, 25(7):1737-1745. 53. Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, Liu X, Li Y, Ward CA, Melo LG: Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Molecular Therapy 2008, 16(3):571-579. 54. Lapidot T, Kollet O: The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m null mice. Leukemia 2002, 16(10):1992. 55. Marquez-Curtis LA, Janowska-Wieczorek A: Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. BioMed research international 2013, 2013. 56. Wang F, Wang L, Zou X, Duan S, Li Z, Deng Z, Luo J, Lee SY, Chen S: Advances in CRISPR-Cas systems for RNA targeting, tracking and editing. Biotechnol Adv 2019, 37(5):708-729. 57. Granados-Riveron JT, Aquino-Jarquin G: CRISPR-Cas13 Precision Transcriptome Engineering in Cancer. Cancer Res 2018, 78(15):4107-4113. 58. O'Connell MR: Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems. J Mol Biol 2019, 431(1):66-87. 59. Ali Z, Mahas A, Mahfouz M: CRISPR/Cas13 as a Tool for RNA Interference. Trends Plant Sci 2018, 23(5):374-378. 60. Terns MP: CRISPR-Based Technologies: Impact of RNA-Targeting Systems. Mol Cell 2018, 72(3):404-412. 61. Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD: Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors. Cell 2018, 173(3):665-+. 62. Engreitz J, Abudayyeh O, Gootenberg J, Zhang F: CRISPR Tools for Systematic Studies of RNA Regulation. Csh Perspect Med 2019, 9(9). 63. Yang LZ, Wang Y, Li SQ, Yao RW, Luan PF, Wu H, Carmichael GG, Chen LL: Dynamic Imaging of RNA in Living Cells by CRISPR-Cas13 Systems. Mol Cell 2019, 76(6):981-997 e987.
|